Business Context and Reporting Period
Company: Nova Measuring Instruments Ltd. (Nova)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date of Report: March 4, 2004
Purpose: This filing incorporates by reference a Notice of Extraordinary General Meeting of Shareholders and a Proxy Statement scheduled for March 31, 2004. The primary purpose is to seek shareholder approval for a new employee stock option plan and specific grants to directors.
Key Financial Metrics
The filing text does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The document focuses exclusively on corporate governance and equity compensation matters.
Capital Structure Data Provided:
- Outstanding Shares: 15,150,000 Ordinary Shares (as of February 25, 2004).
- Par Value: NIS 0.01 per share.
- Voting Rights: One vote per Ordinary Share.
Material Changes and Proposals
The filing details two primary proposals to be voted on by shareholders:
- Framework Employee Stock Option Plan 7:
- Total Authorization: Up to 1,500,000 Ordinary Shares.
- Structure: Divided into three sub-plans (7A, 7B, 7C) covering the years 2004, 2005, and 2006.
- 2004 Allocation (Plan 7A): Up to 600,000 shares.
- 2005-2006 Allocation (Plans 7B & 7C): Up to 900,000 shares combined.
- Vesting: Standard 4-year vesting (25% after 12 months, monthly thereafter), with potential acceleration based on net profit criteria.
- Exercise Price: Fair market value at the time of grant.
- Director Option Grants:
- Total Grant: 180,000 Ordinary Shares to specific directors.
- Allocation:
- Giora Dishon (CEO): 65,000 options
- Moshe Finarov (Director of Technology): 55,000 options
- Michael Brunstein, Avi Kerbs, Joseph Ciechanover, Allon Dumanis, and Karey Holland: 10,000 options each.
- Terms: Exercisable under the terms of Option Plan 7A.
Guidance, Outlook, and Risks
Management Commentary: The Board recommends a "FOR" vote on the Framework Option Plan. The Board expressed no recommendation regarding the specific grant of options to directors, though the grants were approved by the Audit Committee and Board.
Contingencies and Risks:
- Shareholder Approval Condition: The Framework Plan is conditional upon shareholder approval. If not approved, any options issued under the plan shall be invalidated and may not be exercised.
- Change of Control: In the event of a sale of assets or merger, options held for a specific period will be deemed to have been held for one year longer than the actual period, accelerating vesting.
- Tax Liability: Under the plan, tax consequences arising from the grant or exercise of options are borne solely by the optionee, who must indemnify the Company against tax liabilities.
- Termination: Options generally terminate immediately upon dismissal for cause or breach of fiduciary duty.
Investor Verification Checklist
- Verify the final vote outcome of the March 31, 2004 Extraordinary Shareholders Meeting regarding the 1,500,000 share authorization.
- Confirm the specific "net profit criteria" set by the Board that would trigger accelerated vesting, as these were not detailed in the filing.
- Monitor the dilution impact of the 180,000 director options and the potential 1,500,000 employee options against the 15,150,000 outstanding shares.
- Review subsequent filings for the actual number of options granted under Plan 7A in 2004 versus the authorized 600,000.
- Check for any changes in the Company's financial performance that might affect the ability to meet the vesting acceleration criteria.